The Role of Aldosterone on Augmented Exercise Pressor Reflex in Hypertension
The Role of Aldosterone on Augmented Exercise Pressor Reflex in Hypertension
批准号:
8440112
负责人:
WANPEN VONGPATANASIN
金额:
$55.1万
依托单位国家:
美国
项目类别:
财政年份:
2013
资助国家:
美国
项目状态:
已结题
起止时间:
2013-02-01 至 2017-01-31
关键词:
Adrenal GlandsAgeAldosteroneAmlodipineAntihypertensive AgentsAssesAttenuatedBaroreflexBlood CirculationBlood PressureBrainBuffersCapsaicinCardiovascular systemClinicalCongestive Heart FailureConsciousDahl Hypertensive RatsDataDoseEssential HypertensionEthnic OriginExcisionExerciseFunctional disorderGenderGenerationsHeart RateHumanHyperaldosteronismHypertensionInbred SHR RatsInfusion proceduresInterventionKidneyLaboratoriesMeasuresMechanoreceptorsMediatingMediationMethodsMicroelectrodesMineralocorticoid ReceptorModelingMuscleMuscle ContractionMuscle FibersNerveNeuraxisOutcomePathogenesisPatientsPeripheralPressoreceptorsRattusReceptor ActivationReflex actionRestRoleSafetySerumSkinStimulusStretchingSympathetic Nervous SystemTechniquesTestingWorkadenomaarmeffective therapyimprovedindexingneuroregulationnormotensivepublic health relevancereceptive fieldresponsetranslational studytumor
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Hypertensive patients are known to display exaggerated rise in blood pressure (BP) during exercise but the underlying mechanisms are poorly understood. Normally, exercise is accompanied by decreased parasympathetic activity and increased sympathetic activity caused by central command and activation of thin fiber muscle afferents that reflexively increase sympathetic outflow and BP. Traditionally, muscle afferents were dichotomized as metaboreceptors, which are activated slowly and only during intense or ischemic muscle contraction, or mechanoreceptors, which respond quickly to even mild deformation of their receptive fields. The increase in SNA and BP caused by activation of these receptors, known as exercise pressor reflex, is normally buffered by activation arterial baroreceptors, which are reset to operate at higher BP range but at the same level of sensitivity. Our recent work in spontaneously hypertensive rats (SHR) and patients with essential hypertension indicated an exaggerated rise in sympathetic nerve activity (SNA) and BP during muscle contraction even in the absence of congestive heart failure. Furthermore, the latency of the sympathetic response during exercise is much shorter than normal and the threshold level of exercise intensity required to increase muscle SNA is much lower than normal, implicating mechanoreceptor mediation. Mechanisms responsible for overactive exercise pressor reflex (EPR) in hypertension remain unknown but an increasing body of evidence suggested a role for aldosterone in regulating resting central sympathetic outflow in both hypertensive rats and humans. Furthermore, local aldosterone synthesis in the brain has been shown to contribute to sympathetic activation and hypertension in the SHRs and Dahl-salt sensitive rats despite normal circulating levels of aldosterone. Whether aldosterone contributes to excessive sympathoexcitation and BP elevation during exercise remains unknown. Our pilot data in hypertensive rats and humans with normal and elevated serum aldosterone levels demonstrated a major role of aldosterone on exercise pressor reflex via mechanoreflex sensitization. Therefore, we now propose parallel translational studies in hypertensive rats and patients with primary hypertension and secondary form of hypertension caused by adrenal overproduction of aldosterone (primary aldosteronism), using multiple interventions to directly activate muscle mechanoreceptors, metaboreceptors, or arterial baroreceptors during exercise and microelectrode recordings of SNA to measure the reflex response. The distinctive features of this proposal include: (1) the use of state-of- the-art techniques (microelectrode recordings of
SNA) to directly test mechanistic hypotheses in conscious humans; (2) assessment of mechanoreflex using a new paradigm which is developed in our laboratory which evokes sustained elevation in SNA and BP than other methods previously described in humans; and (3) the use of complimentary approach to asses central vs. peripheral effects of aldosterone on neural control of circulation during muscle contraction in the hypertensive rats.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Impact of Intensive Treatment of Systolic Blood Pressure on Brain Perfusion, Amyloid and Tau in Older Adults (IPAT-study)
-
批准号:10425191
-
项目类别:
-
资助金额:$236.95万
-
财政年份:2022
-
负责人:WANPEN VONGPATANASIN
-
依托单位:
Diversity Supplement to "Impact of Intensive Treatment of Systolic Blood Pressure on Brain Perfusion, Amyloid and Tau in Older Adults (IPAT-study)"
-
批准号:10833401
-
项目类别:
-
资助金额:$6.93万
-
财政年份:2022
-
负责人:WANPEN VONGPATANASIN
-
依托单位:
Impact of Intensive Treatment of Systolic Blood Pressure on Brain Perfusion, Amyloid and Tau in Older Adults (IPAT-study)
-
批准号:10673088
-
项目类别:
-
资助金额:$229.14万
-
财政年份:2022
-
负责人:WANPEN VONGPATANASIN
-
依托单位:
Diversity Supplement to "Hypertension, intracranial pulsatility and brain Aβ accumulation in older adults"
-
批准号:10179229
-
项目类别:
-
资助金额:$7.2万
-
财政年份:2017
-
负责人:WANPEN VONGPATANASIN
-
依托单位:
Hypertension, intracranial pulsatility and brain A-beta accumulation in older adults
-
批准号:9975666
-
项目类别:
-
资助金额:$67.2万
-
财政年份:2017
-
负责人:WANPEN VONGPATANASIN
-
依托单位:
The Role of Aldosterone on Augmented Exercise Pressor Reflex in Hypertension
-
批准号:8606888
-
项目类别:
-
资助金额:$54.0万
-
财政年份:2013
-
负责人:WANPEN VONGPATANASIN
-
依托单位:
Neural Mechanism of Thiazide-Induced Insulin Resistance
-
批准号:7340203
-
项目类别:
-
资助金额:$36.98万
-
财政年份:2005
-
负责人:WANPEN VONGPATANASIN
-
依托单位:
Neural Mechanism of Thiazide-Induced Insulin Resistance
-
批准号:6998915
-
项目类别:
-
资助金额:$40.23万
-
财政年份:2005
-
负责人:WANPEN VONGPATANASIN
-
依托单位:
Neural Mechanism of Thiazide-Induced Insulin Resistance
-
批准号:7087600
-
项目类别:
-
资助金额:$2.36万
-
财政年份:2005
-
负责人:WANPEN VONGPATANASIN
-
依托单位:
Neural Mechanism of Thiazide-Induced Insulin Resistance
-
批准号:7173870
-
项目类别:
-
资助金额:$36.98万
-
财政年份:2005
-
负责人:WANPEN VONGPATANASIN
-
依托单位:
Neural Mechanism of Thiazide-Induced Insulin Resistance
-
批准号:6851905
-
项目类别:
-
资助金额:$39.0万
-
财政年份:2005
-
负责人:WANPEN VONGPATANASIN
-
依托单位:
POSTMENOPAUSAL HORMONAL REPLACEMENT THERAPY
-
批准号:6725424
-
项目类别:
-
资助金额:$11.5万
-
财政年份:2002
-
负责人:WANPEN VONGPATANASIN
-
依托单位:
POSTMENOPAUSAL HORMONAL REPLACEMENT THERAPY
-
批准号:6467623
-
项目类别:
-
资助金额:$12.42万
-
财政年份:2002
-
负责人:WANPEN VONGPATANASIN
-
依托单位:
POSTMENOPAUSAL HORMONAL REPLACEMENT THERAPY
-
批准号:6883231
-
项目类别:
-
资助金额:$10.48万
-
财政年份:2002
-
负责人:WANPEN VONGPATANASIN
-
依托单位:
POSTMENOPAUSAL HORMONAL REPLACEMENT THERAPY
-
批准号:7051394
-
项目类别:
-
资助金额:$10.48万
-
财政年份:2002
-
负责人:WANPEN VONGPATANASIN
-
依托单位:
POSTMENOPAUSAL HORMONAL REPLACEMENT THERAPY
-
批准号:6623553
-
项目类别:
-
资助金额:$12.42万
-
财政年份:2002
-
负责人:WANPEN VONGPATANASIN
-
依托单位:
国内基金
海外基金
登录
查看更多内容
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
-
批准号:JCZRLH202601523
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
-
批准号:JCZRQN202500010
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:
-
依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
-
批准号:2025JJ70209
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:雷芬芳
-
依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
-
批准号:--
-
项目类别:面上项目
-
资助金额:--
-
批准年份:2024
-
负责人:万荣
-
依托单位:
甜茶抑制AGE-RAGE通路增强突触可塑性改善小鼠抑郁样行为
-
批准号:2023JJ50274
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2023
-
负责人:贺志明
-
依托单位:
蒙药额尔敦-乌日勒基础方调控AGE-RAGE信号通路改善术后认知功能障碍研究
-
批准号:--
-
项目类别:地区科学基金项目
-
资助金额:33万元
-
批准年份:2022
-
负责人:都义日
-
依托单位:
补肾健脾祛瘀方调控AGE/RAGE信号通路在再生障碍性贫血骨髓间充质干细胞功能受损的作用与机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:52万元
-
批准年份:2022
-
负责人:叶宝东
-
依托单位:
LncRNA GAS5在2型糖尿病动脉粥样硬化中对AGE-RAGE 信号通路上相关基因的调控作用及机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2022
-
负责人:于海兵
-
依托单位:
围绕GLP1-Arginine-AGE/RAGE轴构建探针组学方法探索大柴胡汤异病同治的效应机制
-
批准号:81973577
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2019
-
负责人:辛贵忠
-
依托单位:
AGE/RAGE通路microRNA编码基因多态性与2型糖尿病并发冠心病的关联研究
-
批准号:81602908
-
项目类别:青年科学基金项目
-
资助金额:18.0万元
-
批准年份:2016
-
负责人:刘括
-
依托单位: